GlassScriptPhysician profile
Mary Katherine White
NPI 1073635082
$510.41
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.54 · 2022: $154 · 2023: $198 · 2024: $61.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $159.98 | 2021-2023 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $126.96 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.89 | 2021-2024 | Xifaxan |
| Sunovion Pharmaceuticals INC. | $27.35 | 2022 | |
| Lilly USA, LLC | $24.66 | 2024 | Mounjaro |
| Nevro Corp. | $21.71 | 2021 | |
| Astellas Pharma US INC | $19.58 | 2023 | Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.75 | 2022 | |
| Glaxosmithkline, LLC. | $16.15 | 2023 | Shingrix, Arexvy |
| Sumitomo Pharma America, INC. | $13.88 | 2023 | Gemtesa |
| Amneal Pharmaceuticals LLC | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.